Leaderboards/Global Public Health Policies and Epidemiology

Global Public Health Policies and Epidemiology

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Krishnan Sathishkumar
National Centre for Disease Informatics and Research
2
Megan Lindstrom
RTI International
3
Noluthando Ndlovu
Health Systems Trust
4
Jacqui Wise
Transnational Press London
5
Vishwali Mhasawade
NYU Langone Health
6
Meghan O’Hearn
Tufts University
7
article Editorial
Russian Society of Cardiology
8
Xiaoxiao Jiang Kwete
University of Miami
9
Benjamin Wood
Deakin University
10
Suraj Maiti
Virginia Tech

Rising Stars Papers

1
Breast cancer survival in India across 11 geographic areas under the National Cancer Registry Programme
Cancer|2024
60 cit.
2
Health and Related Indicators, 2023
South African Health Review|2024
50 cit.
3
Global Assessment of Palliative Care Need: Serious Health-Related Suffering Measurement Methodology
Journal of Pain and Symptom Management|2024
25 cit.
4
Global life expectancy to increase by almost five years by 2050, study predicts
BMJ|2024
21 cit.
5
Caregiving for China’s one-child generation: a simulation study of caregiving responsibility and impact on women’s time use
BMJ Global Health|2024
15 cit.
6
Covid-19: Two rare vaccine side effects detected in large global study
BMJ|2024
12 cit.
7
UK-US pharmaceutical deal: NHS will pay billions more for new drugs
BMJ|2025
12 cit.
8
Measles: Birmingham outbreak declared a national incident and likely to spread
BMJ|2024
11 cit.
9
RCP members vote to limit physician associate roles amid calls for president to resign
BMJ|2024
10 cit.
10
Understanding Disparities in Post Hoc Machine Learning Explanation
Unknown Journal|2024
10 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Tsung-Mei Cheng
National Dong Hwa University
2
Peng-Fei Shan
Second Affiliated Hospital of Zhejiang University
3
Leonor Guariguata
KU Leuven
4
Yadi Huang
International Diabetes Federation
5
Shamsa Nasser Ali Hussain Lootah
United Arab Emirates University
6
John W. Stanifer
Munson Medical Center
7
Rasha Al‐Lamee
Imperial College Healthcare NHS Trust
8
Christian Franz
Graduate Institute of International and Development Studies
9
Wilson Salgado Filho
Universidade de São Paulo
10
Nihit Goyal
Delft University of Technology

Emerging Leaders Papers

1
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina
New England Journal of Medicine|2023
213 cit.
2
Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial
The Lancet|2024
83 cit.
3
Predicting European cities’ climate mitigation performance using machine learning
Nature Communications|2022
41 cit.
4
Types of learning and varieties of innovation: how does policy learning enable policy innovation?
Policy & Politics|2024
28 cit.
5
Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial
European Heart Journal|2022
27 cit.
6
Whither policy innovation? Mapping conceptual engagement with public policy in energy transitions research
Energy Research & Social Science|2022
25 cit.
7
Daily angina documentation versus subsequent recall: development of a symptom smartphone app
European Heart Journal - Digital Health|2022
20 cit.
8
Remote digital smart device follow-up in prospective clinical trials: early insights from ORBITA-2, ORBITA-COSMIC, and ORBITA-STAR
European Heart Journal Supplements|2022
20 cit.
9
N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention
Journal of the American College of Cardiology|2024
18 cit.
10
Did it increase energy consumption? A difference-in-differences evaluation of a rural electrification policy in Gujarat, India using night-time lights data
Energy Policy|2023
14 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Sebastian Taylor
Royal College of Paediatrics and Child Health
2
Majid Ezzati
University of Ghana
3
Clodagh O’Gorman
University of Limerick
4
Paul Zimmet
Monash University
5
Isabelle Soerjomataram
Centre international de recherche sur le cancer
6
Alan D López
World Health Organization - Pakistan
7
Jonathan E. Shaw
St Mary's Hospital
8
Irma Virant‐Klun
Ljubljana University Medical Centre
9
Mike Rayner
University of Oxford
10
Christopher J L Murray
Institute for Health Metrics and Evaluation

Current Senior Leaders Papers

1
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
The Lancet|2020
19.2k cit.
2
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
The Lancet|2012
14.3k cit.
3
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
The Lancet|2018
14k cit.
4
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
The Lancet|2017
13.5k cit.
5
Obesity : Preventing and managing the global epidemic
Research at the University of Copenhagen (University of Copenhagen)|2000
13k cit.
6
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
The Lancet|2012
12k cit.
7
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
The Lancet|2020
9.6k cit.
8
The metabolic syndrome—a new worldwide definition
The Lancet|2005
9.3k cit.
9
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
The Lancet|2012
9k cit.
10
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
The Lancet|2018
8.7k cit.

Reagents for Global Public Health Policies and Epidemiology

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

Phospho-S6 Ribosomal Protein (Ser240/244) Antibody

#2215$366
View Evidence →
Cell Signaling TechnologyEvidence 65

PathScan® Phospho-FGF Receptor 4 (panTyr) Sandwich ELISA Kit

#69193$66,129,740
View Evidence →
Cell Signaling TechnologyEvidence 64

MAPKAPK-2 Antibody Sampler Kit

#9329$341
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

NSF Antibody

#2145$317
View Evidence →
Cell Signaling TechnologyEvidence 67

IMP3 (D6U2N) Rabbit Monoclonal Antibody

#57145$161,351
View Evidence →
Cell Signaling TechnologyEvidence 66

GDF15/MIC1 (E5Q8Q) Rabbit Monoclonal Antibody (BSA and Azide Free)

#70830$865
View Evidence →